Choosing Antidepressants

Michael Posternak, MD

Assistant Clinical Professor of Psychiatry, Brown University School of Medicine

Dr. Posternak has disclosed that he has no significant relationships with or financial interests in any commercial companies pertaining to this educational activity. The author has disclosed that triidothyronine and methylphenidate have not been approved by the U.S. Food and Drug Administration for use in the treatment of depression. Please consult product labeling for the approved usage of these drugs.

General Psychiatry

KEYWORDS antidepressants

Medication Fact Book for Psychiatric Practice, Sixth Edition (2022)
Guidance, clinical pearls, and bottom-line assessments covering the medications you use in your...
READ MORE

General Psychiatry
Using SAMe In Clinical Practice with Garrett Rossi, MD
Read More

General Psychiatry
Psychopharm Commandment #6: MAOIs
MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.
Listen now